LMAT - Insider Transaction: George LeMaitre Sells $6.94M Worth Of LeMaitre Vascular Shares | Benzinga
It was reported on March 5, that George LeMaitre, Chairman and CEO at LeMaitre Vascular (NASDAQ:LMAT) executed a significant insider sell, according to an SEC filing.
What Happened: LeMaitre's recent move involves selling 101,478 shares of LeMaitre Vascular. This information is documented in a Form 4 filing with the U.S. Securities and Exchange Commission on Tuesday. The total value is $6,944,096.
In the Tuesday's morning session, LeMaitre Vascular's shares are currently trading at $67.92, experiencing a down of 0.0%.
Unveiling the Story Behind LeMaitre Vascular
LeMaitre Vascular Inc manufactures and distributes medical devices for the treatment of peripheral vascular disease. Its products are primarily used during open vascular surgery and address several anatomical areas, such as the carotid, lower extremities, upper extremities, and aorta. The firm's lower extremities product line contributes the largest proportion of revenue, followed by the carotid product line. LeMaitre's surgical devices include angioscopes, balloon catheters, carotid shunts, phlebectomy devices, vascular grafts, vascular patches, and vessel closure systems. LeMaitre generates the majority of its revenue in the United States.
A Deep Dive into LeMaitre Vascular's Financials
Revenue Growth: Over the 3 months period, LeMaitre Vascular showcased positive performance, achieving a revenue growth rate of 3.1% as of 31 December, 2023. This ...